Add
SUPN to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| SUPN > SEC Filings for SUPN > Form 8-K on 24-Jul-2012 | All Recent SEC Filings |
24-Jul-2012
Other Events, Financial Statements and Exhibits
On July 20, 2012, Supernus Pharmaceuticals, Inc. (the "Company") issued a press release providing details regarding the appointment of Dr. Stefan Schwabe, MD, PhD as Executive Vice-President of Research & Development and Chief Medical Officer. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.
(d) Exhibits
The following document is furnished as an Exhibit pursuant to Item 8.01 hereof:
Exhibit 99.1 - Press Release dated July 20, 2012 of the Company providing details regarding the appointment of Dr. Stefan Schwabe, MD, PhD as Executive Vice-President of Research & Development and Chief Medical Officer.
|
|